QSAR for anti-malarial activity of 2-aziridinyl and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives

被引:14
|
作者
Zahouily, M [1 ]
Lazar, M [1 ]
Elmakssoudi, A [1 ]
Rakik, J [1 ]
Elaychi, S [1 ]
Rayadh, A [1 ]
机构
[1] UFR Chim Appliquee, Lab Catalyse Chimiometrie & Environm, Dept Chim, Mohammadia 20650, Morocco
关键词
2D-QSAR; anti-malarial activity; pertinent descriptors; MLR; ANN;
D O I
10.1007/s00894-005-0059-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quantitative structure-activity antimalarial relationships have been studied for 63 analogues of 2-aziridinyl and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives by means of multiple linear regression (MLR) and artificial neural networks (ANN). The antimalarial activity [-log(IC(50)x10(6))] of the compounds studied were well correlated with descriptors encoding the chemical structure. Using the pertinent descriptors revealed by a stepwise procedure in the multiple linear regression technique, a correlation coefficient of 0.9394 (s=0.2121) for the training set was obtained for the ANN model in a [3-5-1] configuration. The results show that the antimalarial activity of 2-aziridinyl and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives is strongly dependent on hydrophobic character, hydrogen-bond acceptors and also steric factors of the substituents.
引用
收藏
页码:398 / 405
页数:8
相关论文
共 20 条
  • [1] QSAR for anti-malarial activity of 2-aziridinyl and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives
    Mohamed Zahouily
    Mohamed Lazar
    Abdelhakim Elmakssoudi
    Jamila Rakik
    Sanaa Elaychi
    A. Rayadh
    Journal of Molecular Modeling, 2006, 12 : 398 - 405
  • [2] DFT based QSAR studies on 2-aziridinyl and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives as an anti-malarial agent
    Sarkar, Ananda
    Sarkar, Bikash Kumar
    Jana, Atish Dipankar
    JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2020, 97 (9B) : 1590 - 1595
  • [3] SYNTHESIS AND ANTIMALARIAL ACTIVITY OF 2-AZIRIDINYL-1,4-NAPHTHOQUINONYL AND 2,3-BIS(AZIRIDINYL)-1,4-NAPHTHOQUINONYL SULFONATE AND ACYLATE DERIVATIVES
    LIN, TS
    ZHU, LY
    XU, SP
    DIVO, AA
    SARTORELLI, AC
    JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (05) : 1634 - 1639
  • [4] Molecular modeling and 3D-QSAR studies in 2-aziridinyl-and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives as potential antimalarial agents
    Pandey, SK
    Naware, NB
    Trivedi, P
    Saxena, AK
    SAR AND QSAR IN ENVIRONMENTAL RESEARCH, 2001, 12 (06) : 547 - 564
  • [5] MIA-QSAR Coupled to Different Regression Methods for the Modeling of Antimalarial Activities of 2-aziridinyl and 2,3-bis-(aziridinyl)-1,4-naphtoquinonyl Sulfate and Acylate Derivatives
    Goodarzi, Mohammad
    Freitas, Matheus P.
    MEDICINAL CHEMISTRY, 2011, 7 (06) : 645 - 654
  • [6] SYNTHESIS AND ANTIMALARIAL ACTIVITY OF 2- AND 2,3-BIS(AZIRIDINYL)-1,4-NAPHTHOQUINONE SULFONATE DERIVATIVES
    LIN, TS
    XU, SP
    DIVO, AA
    SARTORELLI, AC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1986, 192 : 91 - MEDI
  • [7] SYNTHESIS OF 2,3-BIS(AZIRIDINYL)-1,4-NAPHTHOQUINONE SULFONATE DERIVATIVES AS POTENTIAL ANTINEOPLASTIC AGENTS
    LIN, TS
    XU, SP
    COSBY, LA
    SARTORELLI, AC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1986, 191 : 33 - MEDI
  • [8] POTENTIAL ANTICANCER AGENTS .52. MESO-1,4-BIS(1-AZIRIDINYL)-2,3-BUTANEDIOL
    REIST, EJ
    BAKER, BR
    GOODMAN, L
    CREWS, OP
    JUNGA, IG
    WAIN, ME
    JOURNAL OF ORGANIC CHEMISTRY, 1961, 26 (06): : 2139 - &
  • [9] 2,3-BIS(AZIRIDINYL)-1,4-NAPHTHOQUINONE SULFONATES - A NEW CLASS OF BIOREDUCTIVE ALKYLATING-AGENTS WITH PREFERENTIAL TOXICITY TOWARD HYPOXIC TUMOR-CELLS
    GRAY, MA
    LIN, TS
    XU, SP
    ZHU, LY
    ROCKWELL, S
    SARTORELLI, AC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 260 - 260
  • [10] Anti-malarial activity of some 7-chloro-2-quinoxalinecarbonitrile-1,4-di-N-oxide derivatives
    Aldana, I
    Ortega, MA
    Jaso, A
    Zarranz, B
    Oporto, P
    Giménez, A
    Monge, A
    Deharo, E
    PHARMAZIE, 2003, 58 (01): : 68 - 69